Scott Braunstein
CIK 1643875 · View on SEC EDGAR ↗
First SEC filing: July 22, 2021 · Latest: July 22, 2021
On this page
- Insider at Companies where this person is a reporting insider.
- Insider transactions Every share this person bought or sold, from Form 4 filings.
- Derivatives Options and other derivative holdings reported by this person.
- Initial holdings The stakes this person held when they first started reporting.
- Compensation Executive pay disclosed in company proxy statements.
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| June 5, 2017 | PCRX | S | 768 | $43.32 | $33,270 | 9,982 Direct | -7.14% | Disposed | -44.4% (price as of 2026-08-20) |
| Jan. 29, 2016 | PCRX | P | 2,000 | $58.92 | $117,840 | 2,000 Direct | — | Acquired | -59.1% (price as of 2026-08-20) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Nov. 4, 2025 | ATAI | Stock Option | Common Shares (56,818) | $5.28 | Nov. 4, 2035 | 56,818 | Acquired |
| June 26, 2025 | ATAI | Stock Option | Common Shares (103,000) | $2.25 | June 26, 2035 | 103,000 | Acquired |
| June 13, 2024 | ATAI | Stock Option | Common Shares (206,000) | $1.34 | June 13, 2034 | 206,000 | Acquired |
| Dec. 20, 2021 | CRBU | Option to purchase Common Stock | Common Stock (27,500) | $15.16 | Dec. 19, 2031 | 27,500 | Acquired |
| June 9, 2020 | TARA | Stock Option (Right to Buy) | Common Stock (9,000) | $35.00 | June 8, 2030 | 9,000 | Acquired |
| Jan. 9, 2020 | TARA | Stock Option (Right to Buy) | Common Stock (15,641) | $9.18 | April 28, 2029 | 15,641 | Acquired |
| Jan. 9, 2020 | TARA | Stock Option (Right to Buy) | Common Stock (16,214) | $9.18 | Dec. 3, 2028 | 16,214 | Acquired |
| Jan. 9, 2020 | TARA | Stock Option (Right to Buy) | Common Stock (2,861) | $9.18 | July 11, 2028 | 2,861 | Acquired |
| Jan. 9, 2020 | TARA | Stock Option (Right to Buy) | Common Stock (15,737) | $9.18 | April 28, 2029 | 15,737 | Acquired |
| Jan. 9, 2020 | TARA | Stock Option (Right to Buy) | Common Stock (6,676) | $9.18 | Dec. 31, 2028 | 6,676 | Acquired |
| Jan. 9, 2020 | TARA | Stock Option (Right to Buy) | Common Stock (9,537) | $9.18 | Dec. 31, 2028 | 9,537 | Acquired |
| Jan. 9, 2020 | TARA | Stock Option (Right to Buy) | Common Stock (2,861) | $9.18 | July 11, 2028 | 2,861 | Acquired |
| Jan. 9, 2020 | TARA | Stock Option (Right to Buy) | Common Stock (9,537) | $9.18 | May 24, 2028 | 9,537 | Acquired |
| Dec. 31, 2018 | TCRT | Stock Option (right to buy) | Common Stock (126,700) | $1.87 | Dec. 31, 2028 | 126,700 | Acquired |
| Sept. 18, 2018 | TCRT | Stock Option (Right to Buy) | Common Stock (50,000) | $3.00 | Sept. 18, 2028 | 50,000 | Acquired |
| May 23, 2018 | ESPR | Stock Option (right to buy) | Common Stock (10,100) | $38.32 | May 23, 2028 | 10,100 | Acquired |
| Jan. 3, 2018 | PCRX | Stock Option (Right to Buy) | Common Stock (60,000) | $46.35 | Jan. 3, 2028 | 60,000 | Acquired |
| June 14, 2017 | PCRX | Stock Option (Right to Buy) | Common Stock (22,000) | $44.20 | June 14, 2027 | 22,000 | Acquired |
| June 2, 2017 | PCRX | Stock Option (Right to Buy) | Common Stock (10,000) | $44.10 | June 2, 2027 | 10,000 | Acquired |
| April 17, 2017 | ESPR | Stock Option (right to buy) | Common Stock (14,000) | $38.96 | April 17, 2027 | 14,000 | Acquired |
| Dec. 7, 2016 | PCRX | Stock Option (Right to Buy) | Common Stock (20,000) | $32.35 | Dec. 7, 2026 | 20,000 | Acquired |
| June 15, 2016 | PCRX | Stock Option (Right to Buy) | Common Stock (17,500) | $40.34 | June 15, 2026 | 17,500 | Acquired |
| June 9, 2016 | ESPR | Stock Option (right to buy) | Common Stock (8,000) | $17.75 | June 9, 2026 | 8,000 | Acquired |
| Aug. 19, 2015 | ESPR | Stock Option (right to buy) | Common Stock (20,000) | $57.54 | Aug. 19, 2025 | 20,000 | Acquired |
| July 13, 2015 | PCRX | Employee Stock Option (Right to Buy) | Common Stock (75,000) | $67.11 | July 13, 2025 | 75,000 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 2 holdings
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| July 22, 2021 | CRBU | Stock Option (Right to Buy)→ Common Stock (87,440) | 87,440 | Direct |
| June 15, 2015 | ESPR | Common Stock | 52 | Direct |
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2017 | $440,462 | $158,010 | $486,200 | $657,872 | — | — | $966 | $1,743,510 |
| 2016 | $419,039 | $134,400 | $352,975 | $680,476 | — | — | $966 | $1,587,856 |
| 2015 | $182,308 | $75,000 | — | $2,502,769 | — | — | $630 | $2,760,707 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.